More than 12,000 Americans will be diagnosed with some type of soft tissue sarcoma this year. Sarcoma can be very difficult to treat, particularly when it has metastasized and spread to other parts of the body. Nearly 5,000 people will die from the disease this year, according to the American Cancer Society. New research from Aaron Mansfield, M.D., an oncologist at Mayo Clinic, and George Vasmatzis, Ph.D., the co-director of the Biomarker Discovery Program of Mayo Clinic Center for Individualized Medicine, offers hope for patients with inflammatory myofibroblastic tumors, a rare form of sarcoma.
Read the news release on their research that identifies a cause and potential treatment for inflammatory myofibroblastic tumors.